Updated:
Ambria Capital
Ambria Capital invests in emerging public and private companies in various industries. The firm was founded in 2019 by a team of investment professionals.
Ambria Capital
Ambria Capital invests in emerging public and private companies in various industries. The firm was founded in 2019 by a team of investment professionals. Ambria combines a comprehensive analytical approach with a network of contacts to connect industry leaders with market opportunities.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
San Juan
Corporate office
Brooklyn, United States
Additional offices
Zurich, Switzerland · San Juan, Puerto Rico · Lewes, DE, United States · Highland Park, IL, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Ambria Capital?
Ambria Capital does not publicly name its investment principals. The firm's website, LinkedIn presence, or public filings do not list a founder, CEO, CIO, or managing partners. Institutional allocators seeking governance clarity will find no disclosed decision-making structure.
Which sectors does Ambria Capital specialize in?
Ambria lists four sector focuses on its website: psychedelics, digital health, cryptocurrency, and cybersecurity. The firm's clearest emphasis is on psychedelic-assisted therapies for mental health, which it calls a "massive market opportunity" driven by FDA breakthrough designations and clinical trial success (per its website).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: